It has also been previously reported that while prostate cancer patients had a similar frequency of total Tregs in peripheral blood as healthy donors, the CTLA-4+ Tregs from patients had greater suppressive functionality [53]. The gene discussed is CTLA4; the disease is prostate carcinoma.